Newsbenzinga
Reported Earlier, Twist Bioscience Prices Upsized Public Offering Of 3,125,000 Common Shares At $96.00 Per Share To Fund R&D And Manufacturing Expansion
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…